← All organizations

Minerva Neurosciences

For profitWebsite ↗

Also known as: Minerva Neurosciences

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 13, 2023

Timeline

2000s

Jun 1, 2007
Minerva Neurosciences— Founded

Drugs by trial phase (4 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

roluperidone

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

olanzapine

Indications

Studied for

Recent trials (8)

NCT06107803Lead sponsorPhase 1Oct 13, 2023
NCT03682380CollaboratorPhase 1Oct 1, 2018
NCT03446846Lead sponsorPhase 2Mar 30, 2018
NCT03397134Lead sponsorPhase 3Dec 15, 2017
NCT03227224CollaboratorPhase 2Aug 16, 2017
NCT03072056Lead sponsorPhase 1Jan 9, 2017
NCT03038646Lead sponsorPhase 1Nov 1, 2016
NCT02232529Lead sponsorPhase 1Sep 1, 2014

Details

Founded: Cambridge, MA, US Jun 1, 2007
Last known activity: Oct 13, 2023